Plus   Neg

Leidos Cuts 2020 Outlook - Quick Facts

Leidos Holdings Inc. (LDOS) said it cut its fiscal year 2020 outlook, as a result of the company's year-to-date performance and updated expectations.

The company lowered its annual non-GAAP earnings per share outlook to a range of $5.00 to $5.30, from the prior estimation of $5.30 to $5.65. Analysts polled by Thomson Reuters expect the company to report earnings of $5.44 per share for fiscal year 2020. Analysts' estimates typically exclude special items.

The company now projects annual revenues to be in the range of $12.5 billion to $12.9 billion, compared to the prior outlook of $12.6 billion to $13.0 billion. Analysts expect revenues of $12.68 billion for fiscal year 2020.

The company's updated forward guidance reflects the currently expected impacts related to COVID-19 and the acquisition of L3 Harris' security detection and automation businesses.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT